DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mosapramine
Mosapramine
Centre for Reviews and Dissemination
The Effects of Antipsychotic Treatment on Metabolic Function: a Systematic Review and Network Meta-Analysis
Maternal Use of Psychiatric Medications During Pregnancy And
113.22 Kb
Prohibited Substances List
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Drug and Medication Classification Schedule
United States Patent (19) 11 Patent Number: 5,871,778 Kino Et Al
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Antipsychotics-Children-Surveillance
Electronic Search Strategies
The Efficacy of Garcinia Mangostana L. (Mangosteen) Pericarp As An
Profiles of the Affinity of Antipsychotic Drugs for Neurotransmitter Receptors
Daubert Psychotropics Revised
A Systematic Review of Combination and Volume 1, Issue 1B High-Dose Atypical Antipsychotic Therapy December 2011 in Patients with Schizophrenia
2021 Equine Prohibited Substances List
Atypicality of Several Antipsychotics on the Basis of in Vivo Dopamine
Top View
Drug/Substance Trade Name(S)
(2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
(12) United States Patent (10) Patent No.: US 7,199,151 B2 Shashoua Et Al
(12) United States Patent (10) Patent No.: US 8,314,077 B2 Webb Et Al
Poison Or Antibiotic? a Guide to "Class" Entries
2020 Equine Prohibited Substances List
1 Proposal for Drug Coding of “List of Drugs to Be Prescribed with Special
Generation Antipsychotics for Children and Young Adults Comparative Effectiveness Review Number 39
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Iminodibenzyl Class Antipsychotics for Schizophrenia: a Systematic Review and Meta-Analysis of Carpipramine, Clocapramine, and Mosapramine
KENTUCKY HORSE RACING Chapter: \810\008.020REG
Psychopharmaceuticals in Japan
Pharmaceuticals and Medical Devices Safety Information No
WO 2014/018563 A2 30 January 2014 (30.01.2014)
New Drug Evaluation Monograph Template
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Encyclopedia of Schizophrenia Focus on Management Options W
Summary of Investigation Results Antipsychotic Agents, Etc
A Method for Recruiting Participants for a Study
Technical Commentary
Sustained-Release Microsphere Containing Antipsychotic and Process for Producing the Same
SCHIZOPHRENIA Factsheet March 2019
Association of Hydroxylmethyl Glutaryl Coenzyme a Reductase Inhibitors
Harmonized Tariff Schedule of the United States (2006) (Rev
TESISPRINCEP.Pdf
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
ICD-10-CM Table of Drugs 2019
APPENDIX #2 Proposed Penalty Changes for Class 2 Substances
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid–Antipsychotic Drug Interactions